HYUNDAI BIOSCIENCE CO., LTD. Logo

HYUNDAI BIOSCIENCE CO., LTD.

Clinical-stage biotech developing safer antiviral & anticancer drugs via advanced drug delivery systems.

048410 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경상북도 김천시 아포읍 아포공단길 106, 김천시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

HYUNDAI BIOSCIENCE CO., LTD. is a clinical-stage biotechnology company focused on developing and commercializing innovative therapeutics through its advanced drug delivery systems (DDS) and bio-fusion technologies. The company's core mission is to create safer and more effective treatments for critical diseases. Its development pipeline features CP-COV03, a broad-spectrum antiviral drug candidate designed to treat viral infections by enhancing cellular autophagy, and Polytaxel, a next-generation anticancer agent engineered to minimize toxicity and patient discomfort. The company's proprietary technology platform, utilizing organic-inorganic hybrid materials, also underpins its commercialized bio-functional products. Through strategic partnerships with global universities and companies, Hyundai Bioscience aims to contribute significantly to human health and life extension.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HYUNDAI BIOSCIENCE CO., LTD. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HYUNDAI BIOSCIENCE CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HYUNDAI BIOSCIENCE CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A
CHOSA Oncology AB Logo
Develops diagnostics and targeted therapies to personalize platinum-based cancer treatments.
Sweden CHOSA
CINC Corp. Logo
Offers AI marketing analytics and SEO tools leveraging a vast Japanese keyword dataset.
Japan 4378
CIRCULATION Co.,Ltd. Logo
Connects corporations with experts for project-based consulting to solve business challenges.
Japan 7379
CIZZLE BIOTECHNOLOGY HOLDINGS PLC Logo
Developing a CIZ1B biomarker blood test for the early detection of lung cancer.
United Kingdom CIZ
COPRO-HOLDINGS. Co., Ltd. Logo
Dispatches technical personnel to Japan's construction & plant industries.
Japan 7059
A creator agency connecting professionals in creative, tech, medical, and legal sectors.
Japan 4763
Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.
South Korea 040350
CRG HOLDINGS CO.,LTD. Logo
Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.
Japan 7041
CRONEX.CO.,LTD Logo
CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.
South Korea 215570

Talk to a Data Expert

Have a question? We'll get back to you promptly.